Population
Human and animal failing hearts and in vitro myocyte models
Design
Review
Authors
Loading...
Does not support PDE3A modulation in HF care; leaves open targeted anti-apoptotic strategies pending interventional studies.
Maintaining PDE3A function may represent a therapeutic strategy to prevent myocyte apoptosis and cardiac dysfunction in heart failure.
Chen et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: